LOC100132707 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.146200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.413800E-01
Normal-vs-Stage2
9.869600E-02
Normal-vs-Stage3
2.245800E-01
Normal-vs-Stage4
7.256000E-01
Stage1-vs-Stage2
9.994600E-01
Stage1-vs-Stage3
3.106000E-02
Stage1-vs-Stage4
4.038200E-01
Stage2-vs-Stage3
2.965300E-04
Stage2-vs-Stage4
2.879200E-01
Stage3-vs-Stage4
1.568180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.849600E-02
Normal-vs-AfricanAmerican
5.382000E-01
Normal-vs-Asian
1.298560E-01
Caucasian-vs-AfricanAmerican
3.917600E-01
Caucasian-vs-Asian
3.443400E-01
AfricanAmerican-vs-Asian
3.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.423800E-02
Normal-vs-Female
9.957800E-02
Male-vs-Female
5.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.416200E-01
Normal-vs-Age(41-60Yrs)
1.444020E-01
Normal-vs-Age(61-80Yrs)
7.334100E-02
Normal-vs-Age(81-100Yrs)
3.162400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.371200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.734010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.742200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.210800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.887900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.589800E-01
Normal-vs-Daily Drinker
1.131240E-01
Normal-vs-Weekly Drinker
2.180800E-01
Normal-vs-Occasional Drinker
4.192200E-02
Normal-vs-Social Drinker
4.563800E-01
Non Drinker-vs-Daily Drinker
8.188800E-01
Non Drinker-vs-Weekly Drinker
6.203800E-01
Non Drinker-vs-Occasional Drinker
7.049600E-01
Non Drinker-vs-Social Drinker
2.722400E-02
Daily Drinker-vs-Weekly Drinker
8.021000E-01
Daily Drinker-vs-Occasional Drinker
6.108800E-01
Daily Drinker-vs-Social Drinker
9.623600E-02
Weekly Drinker-vs-Occasional Drinker
4.852400E-01
Weekly Drinker-vs-Social Drinker
2.359400E-01
Occasional Drinker-vs-Social Drinker
2.532200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.596800E-01
Normal-vs-Grade 2
6.082400E-02
Normal-vs-Grade 3
5.274300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.358300E-02
Grade 1-vs-Grade 3
1.251700E-02
Grade 1-vs-Grade 4
2.596800E-01
Grade 2-vs-Grade 3
3.241000E-01
Grade 2-vs-Grade 4
6.082400E-02
Grade 3-vs-Grade 4
5.274300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.913600E-02
Normal-vs-NonDiabetic
6.128400E-02
Diabetic-vs-NonDiabetic
9.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.329200E-01
Normal-vs-NoPancreatitis
6.754200E-02
Pancreatitis-vs-NoPancreatitis
6.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.445700E-02
Normal-vs-N1
9.874100E-02
N0-vs-N1
1.269440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.060370E-01
Normal-vs-TP53-NonMutant
2.121400E-01
TP53-Mutant-vs-TP53-NonMutant
5.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
